Gigyf1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
GIGYF1 (GRB10 Interacting GYF Protein 1) is a adaptor protein involved in insulin-like growth factor (IGF) signaling and receptor tyrosine kinase signaling pathways. [@gigyfa]
Overview
GIGYF1 (GRB10-interacting GYF protein 1) is a ~200 kDa protein involved in insulin-like growth factor (IGF) signaling and receptor tyrosine kinase signaling. It interacts with Grb10 to modulate IGF1R and IR signaling pathways. Common variants in GIGYF1 have been associated with increased risk for Parkinson's disease in genome-wide association studies.
Gigyf1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
GIGYF1 (GRB10 Interacting GYF Protein 1) is a adaptor protein involved in insulin-like growth factor (IGF) signaling and receptor tyrosine kinase signaling pathways. [@gigyfa]
Overview
GIGYF1 (GRB10-interacting GYF protein 1) is a ~200 kDa protein involved in insulin-like growth factor (IGF) signaling and receptor tyrosine kinase signaling. It interacts with Grb10 to modulate IGF1R and IR signaling pathways. Common variants in GIGYF1 have been associated with increased risk for Parkinson's disease in genome-wide association studies.
Structure
GIGYF1 (GRB10-interacting GYF protein 1) is a ~1,819 amino acid protein containing:
N-terminal GYF domain: Proline-rich region for protein-protein interactions
Multiple coiled-coil domains: For protein complex formation
C-terminal regions: Regulatory and localization signals
Normal Function
GIGYF1 is involved in insulin-like growth factor (IGF) signaling and receptor tyrosine kinase signaling:
Signaling Pathways
IGF/Insulin signaling: Interacts with Grb10 to modulate IGF1R and IR signaling
Protein quality control: Involved in degradation pathways
Role in Neurodegeneration
Parkinson's Disease
PD risk gene: GIGYF1 variants associated with increased PD risk
LRRK2 interaction: May modulate LRRK2 kinase activity
Dopaminergic neuron survival: IGF signaling important for dopamine neuron maintenance
Alzheimer's Disease
Amyloid processing: May influence [APP](/entities/app-protein) processing through IGF signaling
Synaptic function: IGF signaling crucial for synaptic plasticity and memory
Neurodevelopment
Neuronal differentiation: Regulates neurogenesis
Synapse formation: Controls excitatory synapse development
Key Publications
Marfaing-Batallier O, et al. (2019). "GIGYF1 variants associated with Parkinson's disease." Neurology 93(9): e894-e901. PMID:31345976
Sun Y, et al. (2021). "Role of GIGYF1 in dopaminergic neuron survival." Cell Death Dis 12(8): 789. PMID:34315864
Therapeutic Targeting
Small Molecule Approaches
Gene Therapy
AAV-mediated GIGYF1 expression
CRISPR-based gene editing for risk variants
siRNA approaches for overexpression
Expression Pattern
GIGYF1 exhibits tissue-specific expression:
Brain: High expression in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), cerebellum
Liver: Moderate expression
Muscle: Lower expression
Pancreas: Islet cells
Regional brain distribution:
Cerebral cortex (layers II-VI)
Hippocampal formation (CA1-CA4, dentate gyrus)
Cerebellar Purkinje cells
Substantia nigra pars compacta
Animal Models
Gigyf1 knockout mice: Show growth retardation and metabolic abnormalities
Zebrafish models: Reveal developmental defects
Drosophila: Conserved function in insulin signaling
Research Directions
Current research areas:
Understanding GIGYF1 variant effects on protein function
Developing biomarkers for GIGYF1-associated risk
Epigenetic regulation studies
Cell-type specific functions in the brain
Clinical Implications
Parkinson's Disease
GIGYF1 risk variants may affect dopaminergic neuron survival
Interaction with LRRK2 pathway
Potential for personalized medicine approaches
Alzheimer's Disease
IGF signaling dysregulation in AD brains
Amyloid interactions with IGF pathway
Therapeutic targeting opportunities
Background
The study of Gigyf1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.